Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hormone-Resistant Prostate Cancer × XRP6258 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 6 Breast Neoplasms 2 Recurrence 1 Prostate Cancer Metastatic 1 Neoplasm Metastasis 1 Metastatic Breast Cancer With Intracranial Metastases 1 Lung Neoplasms 1 Hormone-Resistant Prostate Cancer 1 Diarrhea 1 Castrate-resistant Metastatic Prostate Cancer 1 Brain Neoplasms 1

Interventions

prednylidene 1 deltacortene 1 cabazitaxel 1 XRP6258 1 Prednisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02844582 2021-01-25

Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

University of California, Davis

Phase 2 Terminated

2 enrolled 5 charts

Hormone-Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡